IL-12 targeting could open pathways for new Alzheimer’s treatments Researchers from Charité-Universitätsmedizin Berlin and the Max Delbrück center have detailed the precise mechanism with which the inflammatory signal molecule…
Targeting necroptosis could halt nerve cell loss in Alzheimer’s Alzheimer’s disease is characterized by a progressive loss of nerve cells, leading to a decline in memory and cognition. A…